+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

L

Actively Recruiting

Researchers are evaluating changes in bone mineral density in premenopausal women with heavy menstrual bleeding caused by uterine fibroids or moderate-to-severe pain from endometriosis. This Phase 3B, open-label study looks at the effects of continuous treatment with a relugolix combination tablet for up to 48 months 4 years, followed by a 1-year period to monitor bone health after stopping treatment. Participants will take a daily oral relugolix combination tablet containing relugolix 40 mg, estradiol 1 mg, and norethindrone acetate 0.5 mg for 4 years. Bone mineral density will be measured every 6 months using dual-energy X-ray absorptiometry DXA. Some women who have completed a previous related study may join to complete 3 years of treatment. After treatment ends, bone density will be checked again at 6 months and 12 months during the follow-up year. Women in the study will have regular visits for bone density scans and health assessments, including physical and gynecological exams, lab tests, and vital signs. Researchers will track changes in bone density at the spine, hip, and femoral neck throughout treatment and follow-up. They will also monitor for any fractures or adverse events during the 4 years of treatment and the 1-year post-treatment period. Total participation can last up to 5 years including the follow-up.

Age: 18Years - 50YearsFEMALEPhase 3
120 locations
E

Actively Recruiting

Healthy Volunteer

Researchers are investigating the safety and effectiveness of Fertilo compared to Medicult IVM for in vitro maturation IVM of eggs in women aged 18 to 35. The study aims to find out if Fertilo leads to better pregnancy outcomes, specifically looking at the number of ongoing pregnancies at 12 weeks gestation. This phase III randomized trial compares these two methods to improve infertility treatment. Participants will be randomly assigned to one of two groups. In the first group, immature eggs surrounded by supportive cells are cultured in Fertilo for 30 hours. In the second group, the eggs are cultured in the standard Medicult IVM system for the same duration. After maturation, eggs in both groups are fertilized, grown to the blastocyst stage, frozen, and later transferred for reproductive purposes. During the study, participants will undergo assessments including hormone level measurements, ultrasounds, and sperm analysis for male partners. Researchers will track several outcomes such as egg maturation rate, fertilization success, embryo development, pregnancy rates, and live births. The trial includes safety monitoring and follow-up until at least 12 weeks of pregnancy, with the total study period expected to last until early 2028.

Age: 18Years - 35YearsFEMALEPhase 3
16 locations